核工业二七二厂生化分厂是一个职工人数不足百人,固定资产不足200万元的民品小厂,起点低、技术差、成本高,以前连年亏损。近两年来分厂坚持用发展的办法解决前进中的问题,技术创新、市场销售、内部管理“三管齐下”,促进了分厂的发展。继去年7月份新建一条年产5000吨聚合硫酸铁生产线之后,目前一条年产2万吨、投资近千万元的生产线正在兴建。产品销售覆盖国内十余个省市,并进入了国际市场。生化分厂原有聚合硫酸铁、蛋白酶、钼酸铵三条生产线。聚合硫酸铁是一种新型环保产品,为了提高产品性能,扩大应用领域,分厂经过几个月的试验研制, Nuclear Industry 272 Plant Biochemical Branch is a small factory with less than 100 employees and less than 2 million yuan in fixed assets. Its starting point is low, its technology is poor, its cost is high, and it has been losing money in successive years. Over the past two years Branch adhere to the development of ways to solve the problems in progress, technological innovation, marketing, internal management, “three-pronged” to promote the development of branch. Following the construction of a new 5,000-ton polymerized ferric sulfate production line in July last year, a production line with an annual output of 20,000 tons and an investment of nearly 10 million yuan is under construction. Product sales cover more than 10 domestic provinces and cities, and entered the international market. Biochemical factory original polyferric sulfate, protease, ammonium molybdate three production lines. Polyferric sulfate is a new type of environmentally friendly products, in order to improve product performance, expand the application areas, branch after several months of trial development,